CCK-8 modulation of mesolimbic dopamine: Antagonism of amphetamine-stimulated behaviors

L. H. Schneider, Jonathan E. Alpert, S. D. Iversen

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Rats (N=15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 μl of: (a) artificial CSF only (VEH), (b) 1.25 μg desulfated CCK (DS-CCK), or (c) 1.25 μg sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N=2) or sulfated CCK (N=2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, "velocity" (number of squares crossed per second in locomotion) and "vertical stability" (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.

Original languageEnglish (US)
Pages (from-to)749-753
Number of pages5
JournalPeptides
Volume4
Issue number5
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Sincalide
Amphetamine
Ventral Tegmental Area
Rats
Dopamine
antineoplaston A10
Nucleus Accumbens
Modulation
Locomotion
Dextroamphetamine
Tegmentum Mesencephali
Body Regions
Cells
Testing
Cannula

Keywords

  • A10 mesolimbic
  • Amphetamine behaviors
  • Cholecystokinin
  • Dopamine
  • Nucleus accumbens
  • Ventral tegmental area

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

CCK-8 modulation of mesolimbic dopamine : Antagonism of amphetamine-stimulated behaviors. / Schneider, L. H.; Alpert, Jonathan E.; Iversen, S. D.

In: Peptides, Vol. 4, No. 5, 1983, p. 749-753.

Research output: Contribution to journalArticle

@article{31a7cbca071a46cb8e5c47031b10b3a4,
title = "CCK-8 modulation of mesolimbic dopamine: Antagonism of amphetamine-stimulated behaviors",
abstract = "Rats (N=15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 μl of: (a) artificial CSF only (VEH), (b) 1.25 μg desulfated CCK (DS-CCK), or (c) 1.25 μg sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N=2) or sulfated CCK (N=2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, {"}velocity{"} (number of squares crossed per second in locomotion) and {"}vertical stability{"} (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.",
keywords = "A10 mesolimbic, Amphetamine behaviors, Cholecystokinin, Dopamine, Nucleus accumbens, Ventral tegmental area",
author = "Schneider, {L. H.} and Alpert, {Jonathan E.} and Iversen, {S. D.}",
year = "1983",
doi = "10.1016/0196-9781(83)90031-1",
language = "English (US)",
volume = "4",
pages = "749--753",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - CCK-8 modulation of mesolimbic dopamine

T2 - Antagonism of amphetamine-stimulated behaviors

AU - Schneider, L. H.

AU - Alpert, Jonathan E.

AU - Iversen, S. D.

PY - 1983

Y1 - 1983

N2 - Rats (N=15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 μl of: (a) artificial CSF only (VEH), (b) 1.25 μg desulfated CCK (DS-CCK), or (c) 1.25 μg sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N=2) or sulfated CCK (N=2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, "velocity" (number of squares crossed per second in locomotion) and "vertical stability" (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.

AB - Rats (N=15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 μl of: (a) artificial CSF only (VEH), (b) 1.25 μg desulfated CCK (DS-CCK), or (c) 1.25 μg sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N=2) or sulfated CCK (N=2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, "velocity" (number of squares crossed per second in locomotion) and "vertical stability" (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.

KW - A10 mesolimbic

KW - Amphetamine behaviors

KW - Cholecystokinin

KW - Dopamine

KW - Nucleus accumbens

KW - Ventral tegmental area

UR - http://www.scopus.com/inward/record.url?scp=0021043209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021043209&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(83)90031-1

DO - 10.1016/0196-9781(83)90031-1

M3 - Article

C2 - 6318205

AN - SCOPUS:0021043209

VL - 4

SP - 749

EP - 753

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 5

ER -